ClinicalTrials.gg
CompletedNCT03351491SmartcheckUpdated May 8, 2018

Use of Smartphone Health Applications Among Patients Aged 18 to 69 Years Recruited in Primary Care in Grenoble Area

An observational study in Mobile Applications and Mobile Health, sponsored by University Grenoble Alps. Completed at 13 sites in France. Open to participants aged 18 Years to 69 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-05-08.

Sponsored by University Grenoble Alps · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
597
Ages
18 Years to 69 Years
Sex
All
01

Study summary

This study evaluates the frequency of use of smartphone health applications among people consulting in primary care in the Grenoble region, France.

This is a descriptive study using a questionnaire completed by the patient and distributed by general practitioners. The study also collects the type of used application as well as the rhythm of usage, and compares the use of mobile health applications according to the sociodemographic, geographical and medical characteristics of the studied population.

Read the detailed description

Smartphones are more and more present and change many aspects of people's life, especially in the field of health. The appearance of numerous mobile health applications over the past years explains this strong attractiveness.

According to some studies, these could lead to savings in health care systems by promoting a preventive approach and refocusing cares on the patient who would be more independent. However, not much data on the use of smartphone health applications by patients are reported in the scientific literature.

The main objective of this study is to evaluate the frequency of use of smartphone mobile health applications among primary care patients aged 18 to 69 in the Grenoble region, France.

The secondary objectives are the collection of the kind of application used, the rhythm of usage of these health applications and the comparison of the frequency of use with the sociodemographic, geographical and medical characteristics of the studied population.

To this end, the investigators use a questionnaire distributed by voluntary general practitioners and filled by patients. The number of subjects to be included is 385 and the number of distributed questionnaires is 1500.

02

Conditions studied

  • Mobile Applications
  • Mobile Health

Keywords

  • Health mobile applications
  • Apps
  • mhealth
  • ehealth
  • France
  • msanté
  • applications mobiles
03

In context

Lead sponsor

University Grenoble Alps is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 69 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Population recruited in 12 general practictioners and 1 primary care center in Grenoble area in France.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged among 18 to 69 years old who consults a general practitioner regardless of the reason for consultation

Exclusion criteria

Exclusion Criteria:

  • patients aged 17 and less and patients aged 70 years and over.
  • Patients not owning a mobile phone and / or smartphone for own
  • Patients deprived of their liberty by judicial or administrative decision or subject to a legal protection measure
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
597 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Use of at least one mobile health application on a smartphone

    Use of at least one mobile health application on a smartphone since the first use of a smartphone.

    Time frame: month 1

Secondary outcomes

  1. Socio-demographic characteristics

    Age (years) Sex (F/M) socio-professional group

    Time frame: month 1

  2. Geographical characteristics

    Postcode

    Time frame: month 1

  3. Names of applications used by the patient

    The patient name the applications which he used. In order to help him/her , there are some examples of kind of applications.

    Time frame: month 1

  4. Origin of the awareness of the existence of the mobile health application used.

    How the patient became aware of the existence of used application: general practitioners, other doctors, other health professionals, media, social circle

    Time frame: month 1

  5. Number of drugs on the prescription

    number of drugs on the prescription.

    Time frame: month 1

  6. Illness requiring treatment for more than a year

    Diabetes, malignant tumor, psychiatric condition, cardiac diseases, rheumatological diseases, pulmonary diseases, chronic renal failure, other

    Time frame: month 1

07

Study locations

13 sites
  • Dr Ronflet
    Chabons, 38690, France
  • Centre de santé de l'abbaye
    Grenoble, 38000, France
  • Dr CROS
    Grenoble, 38000, France
  • Dr Grasset
    Grenoble, 38000, France
  • Dr Riehl
    La Côte-Saint-André, 38260, France
  • Dr Fuentes
    Meylan, 38240, France
  • Maison médicale Moirans
    Moirans, 38430, France
  • Dr PARADIS
    Montmelian, 73800, France
  • Dr Chatellard
    Saint-Martin-d'Hères, 38400, France
  • Dr Moulis
    Saint-Martin-d'Hères, 38400, France
  • Maison médicale Saint Martin d'Hères
    Saint-Martin-d'Hères, 38400, France
  • Maison Médicale de Tullins
    Tullins, 38210, France
  • Dr Bichon
    Villard de Lans, 38250, France
08

References and documents

Publications

  • Paradis S, Roussel J, Bosson JL, Kern JB. Use of Smartphone Health Apps Among Patients Aged 18 to 69 Years in Primary Care: Population-Based Cross-sectional Survey. JMIR Form Res. 2022 Jun 16;6(6):e34882. doi: 10.2196/34882. PubMed 35708744 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2017 to primary completion in Jan 2018, 1 month.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 8, 2017
First posted
Nov 22, 2017
StartActual
Nov 30, 2017
Primary completionActual
Jan 7, 2018
CompletionActual
Jan 14, 2018
Last update
May 8, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 8, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03351491
Lead sponsor
University Grenoble Alps
Responsible party
Roussel Jérémy (Principal Investigator, University Grenoble Alps) — Principal investigator
First posted
Nov 22, 2017
Start date
Nov 30, 2017
Primary completion
Jan 7, 2018
Completion
Jan 14, 2018
Last update
May 8, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion